The present invention relates to novel bifunctional chelates that are based on asymmetrical cyclen derivatives. The chelates contain either three acetates and one methylphosphonic arm or three acetates and one methylphosphonic arm enabling to link the chelate through P-alkyl within phosphoric acid derivative or through P—O-alkyl within phosphonic derivative to any organic back-bone suited for targeting. Suitable targeting moieties are monoclonal antibodies, their fragments and recombinant derivatives such as single chain antibodies, diabodies, triabodies, humanized, human or chimeric variants but also peptides, aptamers, spiegelmers, nucleotides, anti sense oligomers and conventional small molecules. These novel bifunctional chelates are suited for the production of kits for the routine labelling of targeting moieties to be used in radiotherapy with radiometals such as Yttrium-90, or for Magnetic Resonance Imagining (MRI) using Gadolinium.
本发明涉及基于不对称环烯衍
生物的新型双功能螯合物。这些螯合物含有三个
乙酸酯和一个
甲基膦酸臂,或三个
乙酸酯和一个
甲基膦酸臂,从而能够通过
磷酸衍
生物中的 P-烷基或
膦酸衍
生物中的 P-O 烷基将螯合物与任何适合靶向的有机骨架连接起来。合适的靶向分子包括单克隆
抗体、其片段和
重组衍
生物,如单链
抗体、二
抗体、三
抗体、人源化、人源化或嵌合变体,也包括肽、aptamers、spiegelmers、核苷酸、反义寡聚体和传统小分子。这些新型双功能螯合物适用于生产试剂盒,用于对放射治疗中使用的放射性同位素(如
钇-90)或磁共振成像(MRI)中使用的
钆进行常规靶标标记。